Cranial Stabilization Devices Market to Witness Upward Trend with Approval of Spinal Stabilization System
The cranial
stabilization devices market is expected to witness significant growth in the
foreseeable future due to various factors such as high incidence of neurological
disorders, increasing geriatric population, and high number of emergency
surgeries.
Impact
of Neurological Disorders on Cranial Stabilization Devices Market Growth
Neurological disorders
include, acute spinal cord injury, Alzheimer's disease, brain tumors, cerebral
aneurysm, epilepsy, and others. Cranial stabilization devices are designed for
patient positioning in the prone, supine, and sitting positions during
surgeries involving the brain and neck. According to Alzheimer’s Association,
around 5.8 million people in the U.S. aged 65 and older are living with
Alzheimer's dementia in 2020. Such trend suggests high cranial
stabilization devices market in North America.
The U.S is also
witnessing high incidence of brain tumor. According to The Central Brain Tumor
Registry of the United States (2020 CBTRUS Statistical Report), the incidence
rate of all primary malignant and non-malignant brain and other central nervous
system tumors in the U.S was 23.79 cases per 100,000 for a total count of
415,411 incident tumors. Such trend suggests high cranial stabilization devices
market in the U.S.
Relation
between Growing Geriatric Population and Growth of Cranial Stabilization
Devices Market
Geriatric population is
prone to various orthopedic and neurological diseases that involve use of cranial
stabilization devices. According to United Nations Population
Fund, geriatric population in Asia Pacific is expected to triple between 2010
and 2050 to reach 1.3 billion people by 2050. This also suggests significant
demand for cranial stabilization devices in Asia Pacific.
Geriatric
population, as earlier mentioned, is vulnerable to orthopedic diseases.
Treatment of such diseases may require the use of cranial stabilization devices.
According to researchers at the National Spinal Cord Injury Statistical Center
at University of Alabama at Birmingham, as of 2019, 17,730 new spinal cord injury
cases occur annually and between 249,000 and 363,000 people are currently
living with spinal cord injuries in the U.S.
New Developments in Cranial
Stabilization Devices Market
In
November 2020, the U.S. Food and Drug Administration gave 510(k) clearance to SeaSpine
Holdings Corporation's Mariner Cap System that is used to offer temporary stabilization
as a bone anchor during the development of solid bony fusion and aid in the
repair of bone fractures. SeaSpine Holdings Corporation is a
U.S.-based manufacturer of surgical solutions for the treatment of patients
suffering from spinal disorders.

Comments
Post a Comment